UBS Group »

Aspire Biopharma Holdings shares owned by UBS Group

Quarter-by-quarter ownership of Aspire Biopharma Holdings shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aspire Biopharma Holdings

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Holdings held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Holdings by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $197k 192k 1.03

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Aspire Biopharma Holdings

UBS Group
Morgan Stanley
Geode Capital Management
Crewe Advisors
Vanguard Capital Management
Toronto-Dominion Bank
Vanguard Fiduciary Trust
Citigroup
Efficient Wealth Management
SBI Securities
Caitong International Asset Management

View all funds holding Aspire Biopharma Holdings